Pharmacodynamics
Pharmacodynamics (PD) describes what the molecule does to the organism, mirroring pharmacokinetics. It quantifies the relationship between systemic exposure to a compound and the intensity of the observed biological effect on a pharmacological marker: glucose levels for GLP-1 agonists, cell proliferation for regenerative peptides, gene expression for signaling peptides.
Fundamental pharmacodynamic parameters center on the sigmoid dose-response curve. Potency (EC50) represents the concentration producing 50% of maximum effect; efficacy (Emax) designates the maximum response amplitude achievable; Hill slope reflects receptor system cooperativity. Two molecules may share the same EC50 but differ radically in Emax: a partial agonist reaches a plateau lower than a fully effective agonist, even at receptor saturation.
Preclinical peptide studies systematically integrate pharmacokinetics and pharmacodynamics in coupled PK/PD analyses. The objective is to relate measured plasma exposure (AUC, Cmax) to tissue effect magnitude, in order to identify the therapeutic window: concentration range producing the desired effect without activating compensatory or toxic pathways. This PK/PD approach guided optimization of semaglutide and tirzepatide, where extended half-life enabled stable weekly exposure.
Several pharmacodynamic phenomena deserve particular vigilance in peptide research. Tachyphylaxis designates rapid response decrease despite maintained plasma concentration, often through receptor internalization. Tolerance corresponds to slower but similar adaptation. The reverse phenomenon, sensitization, is observed for certain neuropeptides after intermittent exposure. Biased peptides preferentially activate one intracellular signaling pathway (G-protein or β-arrestin) over the other, with major pharmacodynamic consequences on side effect profile.
On lab-peptides-france.com, product data sheets include published pharmacodynamic data (EC50, selectivity between receptor subtypes, relative efficacy) to enable researchers to calibrate their experimental protocols. Understanding a peptide's pharmacodynamics means understanding the language through which this molecule dialogues with its biological targets.